Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • Advancing NeuroMRI with High-Relaxivity Contrast Agents
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • Advancing NeuroMRI with High-Relaxivity Contrast Agents
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates


Improved Turnaround Times | Median time to first decision: 12 days

Case of the Month

Section Editor: Nicholas Stence, MD
Children's Hospital Colorado, Aurora, CO

Submit a Case Previous Cases

April 2022
  • Description
  • Week 1
  • Week 2
  • Week 3
  • Week 4
  • Discussion
Loading

Next Case of the Month Coming May 10...

Primary Glioblastoma

  • Background:
    • This case illustrates the work-up of multifocal hemorrhagic mass lesions. The patient underwent right parietal craniotomy for resection of the mass lesions. Excisional biopsy results confirmed primary glioblastoma, WHO grade IV, IDH wild-type. The case is atypical because of the rare age and imaging presentation of a primary brain malignancy.
    • Glioblastoma (GBM) is another term for WHO grade IV astrocytoma according to the revised WHO 2016 criteria. The primary division is based on whether the tumor is thought to arise de novo (primary) or from another source (secondary). IDH gene mutations are associated with improved survival, but predominantly found in secondary GBM.
    • GBM is the most common primary intracranial neoplasm in adults, occurring predominantly after the age of 40 years with peak incidence in the 60s–70s.
    • Primary GBM is much less common in children and accounts for only approximately 5% of all pediatric CNS tumors. There is a slight male predominance.
  • Clinical Presentation:
    • There is a spectrum of initial presenting symptoms based on tumor location.
    • Common presenting symptoms include focal neurologic deficits, mental status changes, and seizures.
    • Typically, patients present with symptom onset in less than 3 months.
  • Key Diagnostic Features:
    • The supratentorial white matter is the most common location. Multifocal disease is rare and only seen in approximately 5–20% of cases.
    • Classic CT findings include large masses that are iso- or mildly hyperattenuating. There is typically mass effect, surrounding vasogenic edema, and thick/irregular/heterogeneous peripheral enhancement.
    • Glioblastomas may also have a necrotic core or hemorrhagic component. GBM is also known to cross the corpus callosum and/or the commissures to involve the contralateral hemisphere.
    • Contrast-enhanced MRI is considered the most sensitive imaging modality.
    • Advanced MRI techniques, including perfusion imaging (PWI), MRS, and DWI, allow for enhanced surgical and radiotherapy treatment planning.
  • Differential Diagnoses:
    • Hemorrhagic metastatic disease: For example, from melanoma, testicular choriocarcinoma, or a primary thyroid malignancy. Cerebral metastases are usually centered at the gray-white matter junction with associated edema. CT CAP, US thyroid, and US scrotum were negative, so occult primary was considered less likely.
    • Multifocal abscess: Usually demonstrates peripheral enhancement and central restricted diffusion. The patient was also afebrile with normal labs at presentation. Additional infectious/inflammatory work-up was within normal limits.
    • Lymphoma: Should be highly considered in immunocompromised patients. Classically hyperdense masses on CT that demonstrate homogeneous enhancement. Corpus callosum involvement can be seen. Ring enhancement may be seen in immunosuppressed patients.
  • Treatment:
    • Independent predictors of longer patient survival include age <45 years, extent of resection, and MGMT methylation status. MGMT promoter hypermethylation improves prognosis by increasing sensitivity to alkylating agents.
    • Predictive response markers can substantially improve clinical outcomes in patients with high-grade gliomas. For example, 1p/19q codeletion is associated with improved response to chemotherapy.
    • Excisional biopsy and surgical debulking/removal are the most common initial treatments. Postoperative adjuvant chemoradiation is secondary.
    • MRI is utilized for close monitoring for residual or recurrent tumor.

Suggested Reading

  1. Johnson DR, Guerin JB, Giannini C, et al. 2016 updates to the WHO Brain Tumor Classification System: what the radiologist needs to know. RadioGraphics 2017;37:2164–80
  2. Toh CH, Castillo M. Early-stage glioblastomas: MR imaging–based classification and imaging evidence of progressive growth.  AJNR Am J Neuroradiol 2017;38:288–93
  3. Yamashita K, Hiwatashi A, Togao K, et al. MR imaging–based analysis of glioblastoma multiforme: estimation of IDH1 mutation status. AJNR Am J Neuroradiol 2016;37:58–65

Current Issue

American Journal of Neuroradiology: 46 (7)
American Journal of Neuroradiology
Vol. 46, Issue 7
1 Jul 2025
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Sign up for alerts
Advertisement

Case Collections

Clasic Case Archive
Case of the Week Archive
Case of the Month Archive
Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire